PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsReplens
Replens
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
114 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248HP_0002019K59.0121215
Irritable bowel syndromeD043183EFO_0000555K58121913
Type 2 diabetes mellitusD003924EFO_0001360E11257
HypercholesterolemiaD006937HP_0003124167
SyndromeD01357712126
HyperlipidemiasD006949HP_0003077E78.51113
DiarrheaD003967HP_0002014R19.71113
InfertilityD007246HP_0000789112
Urinary incontinenceD014549HP_0000020R32112
DyslipidemiasD050171HP_000311911
Show 4 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fecal incontinenceD005242R153247
Cardiovascular diseasesD002318HP_0001626156
DyspareuniaD004414HP_0030016112
Heart diseasesD006331EFO_0003777I51.9112
Bacterial conjunctivitisD003234EFO_1000829H10.011
ConjunctivitisD003231HP_0000509H1011
AtrophyD00128411
MenopauseD008593EFO_0003922N9511
Intervertebral disc displacementD007405EFO_100180011
Coronary diseaseD00332711
Show 15 more
Indications Phases 2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Congenital abnormalitiesD000013EFO_0003915Q89.911
Urinary tract infectionsD014552EFO_0003103N39.011
Urogenital abnormalitiesD01456411
DysuriaD053159EFO_0003901R3011
HemochromatosisD006432EFO_1000642E83.1111
HemosiderosisD00648611
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OverweightD050177E66.344
Heart disease risk factorsD00008274233
Diabetes mellitusD003920HP_0000819E08-E1333
Healthy dietD00007200133
Kidney diseasesD007674EFO_0003086N0833
Chronic kidney failureD007676EFO_0003884N18.922
Renal dialysisD006435EFO_0010690Z99.222
Body weightD001835EFO_000433822
PapillomaviridaeD02738322
PapillomaD01021222
Show 52 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use